Artificial Intelligence and healthcare -- impending revolution or hype machine? - MedCity News

Other partnerships focusing on early-stage discovery technologies include Insitro, started by Coursera co-founder Daphne Koller. Attracting investments from a high-powered group of venture capital firms including Andreessen Horowitz, GV (formerly Google Ventures), Third Rock, ARCH Venture Partners and Foresite Capital, Insitro plans to train machine learning models to help "address key problems in the drug discovery and development process," according to a blog post by Koller. The company's ambitious goal is to create a way to develop drugs that are cheaper, faster and have a higher success rate than traditional models. Doing her part to minimize over-promising claims, Koller noted in the post that she does not expect this approach to offer a "magic bullet" so much as add another option for drug developers.